[go: up one dir, main page]

PH12012501264A1 - Oxyntomodulin peptide analogue - Google Patents

Oxyntomodulin peptide analogue

Info

Publication number
PH12012501264A1
PH12012501264A1 PH1/2012/501264A PH12012501264A PH12012501264A1 PH 12012501264 A1 PH12012501264 A1 PH 12012501264A1 PH 12012501264 A PH12012501264 A PH 12012501264A PH 12012501264 A1 PH12012501264 A1 PH 12012501264A1
Authority
PH
Philippines
Prior art keywords
peptide analogue
oxyntomodulin peptide
oxyntomodulin
analogue
obesity
Prior art date
Application number
PH1/2012/501264A
Inventor
Wayne David Kohn
Jorge Alsina-Fernandez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2010/060380 external-priority patent/WO2011087671A1/en
Publication of PH12012501264A1 publication Critical patent/PH12012501264A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides Oxyntomodulin peptide analogues useful in the treatment of diabetes and/or obesity.
PH1/2012/501264A 2009-12-22 2010-12-15 Oxyntomodulin peptide analogue PH12012501264A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28888409P 2009-12-22 2009-12-22
PCT/US2010/060380 WO2011087671A1 (en) 2009-12-22 2010-12-15 Oxyntomodulin peptide analogue

Publications (1)

Publication Number Publication Date
PH12012501264A1 true PH12012501264A1 (en) 2013-02-04

Family

ID=94236438

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/501264A PH12012501264A1 (en) 2009-12-22 2010-12-15 Oxyntomodulin peptide analogue

Country Status (1)

Country Link
PH (1) PH12012501264A1 (en)

Similar Documents

Publication Publication Date Title
TN2012000303A1 (en) Oxyntomodulin peptide analogue
TN2012000302A1 (en) Oxyntomodulin peptide analogue
GEP20146056B (en) Acylated glucagon analogues
UA104605C2 (en) Glucagon analogues
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
MX2012001346A (en) Modified factor ix polypeptides and uses thereof.
MX2012009748A (en) Use of transforming growth factor - beta 1 (tgf-î²1) inhibitor peptides for the treatment of corneal fibrosis and/or haze.
GB2465677B (en) Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes
ZA200800464B (en) Peptides for use in the treatment of obesity
IL210810B (en) Peptides for the treatment of pain and/or inflammation
JO3330B1 (en) Cgrp antibodies
MX2010006823A (en) Methods for the treatment of gout.
EP3593802A3 (en) Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
JO3635B1 (en) Solid pharmaceutical compositions and processes for their production
WO2009128867A3 (en) Recombinant biologically contained filovirus
MX2009011346A (en) Tapentadol for treating pain from arthritis.
MX2010010457A (en) Recombinant rhinovirus vectors.
MX2009013682A (en) Hydrolysable polymeric fmoc-linker.
IN2012DN00928A (en)
PH12012501264A1 (en) Oxyntomodulin peptide analogue
UA106465C2 (en) Oxyntomodulin peptide analogue
CL2012000355A1 (en) Compounds derived from 4-amino-butenamide; pharmaceutical composition; and use in the treatment of COPD.
ECSP12011991A (en) OXINTOMODULIN PEPTIDE ANALOG
TW200740726A (en) Aqueous N-methylolmethacrylamide/methacrylamide mixture
CY1115268T1 (en) ANTI-OXIDOMONTOULINE PIPE